Genzyme Accepts CMS Decision To Delay Oral Drug Inclusion
Genzyme said as per the final rule, these medications, including its Renvela (sevelamer carbonate), will not be included in the bundle until January 1, 2014. Renvela is indicated
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.